X4 Pharmaceuticals
Wendy Magnan is an experienced professional in clinical data management with a comprehensive background in the pharmaceutical and clinical research sectors. Currently serving as the Director of Clinical Data Management at X4 Pharmaceuticals since April 2022, Wendy previously held significant roles at GSK as an Associate Director/Manager, Support Analyst, where responsibilities included ensuring compliance and data integrity of EDC systems, managing vendor oversight, and leading data integrity initiatives. Prior positions also include Associate Director of Clinical Systems and Reporting at TESARO, Technical DM at Premier Research, and Manager of Data Analysts and Protocol Registrars at Dana-Farber Cancer Institute. Wendy holds a Master of Public Health in Health Policy and Administration from Yale University and a Bachelor's degree from Connecticut College.
X4 Pharmaceuticals
3 followers
X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and certain cancers. The company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance.